Wall Street analysts say Inogen is cornering the oxygen concentrator market with FDA clearance for its lighter, quieter Inogen At Home system.
Wall Street is looking for Inogen (NSDQ:INGN) to make a big splash with its new Inogen At Home oxygen concentration system, which won FDA clearance today.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mkNLtP
Cap comentari:
Publica un comentari a l'entrada